Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

27
Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011

Transcript of Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Page 1: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Ken Wassum & Abigail Halperin

Session 13: Behavioral Counseling and Pharmacotherapy

09/14/2011

Page 2: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Counseling & Pharmacotherapy

Page 3: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Who Calls the Quitline?

• Smoked / used tobacco >20 years• Not well educated• Lower income• Motivated to quit• Confidence lower than motivation• Chronic illness• High nicotine dependence

Page 4: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Theoretical Counseling Models

Social Cognitive Theory

Transtheoretical Stages of Change

Brief Solution Focused Therapy

Page 5: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Counseling Tools

Cognitive Behavioral

Motivational Interviewing

Education

Modeling

Skill building

Reinforcement

Page 6: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.
Page 7: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.
Page 8: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Counseling Focus

Tobacco only Tobacco only

Counselor backgrounds

Counselor backgrounds

Counselor training

Counselor training

Page 9: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Facilitation Goals

• Develop rapport and trust• Get clarity on outcome goal • Provide encouragement • Enhance motivation and confidence• Demonstrate empathy and non-judgment• Engage the caller in the quitting process• Demonstrate subject matter expertise

Page 10: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Content Goals

• Provide basic information about the nature of tobacco use and dependence

• Educate caller about what to expect when quitting• Help caller create a plan to quit• Teach problem-solving and coping skills• Provide medication decision support• Address relapse prevention

Page 11: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Smoke-free policies

Smoke-free policies Tobacco-taxTobacco-tax

Article 14Article 14Healthcare

referralHealthcare

referral

Page 12: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Integrating Pharmacotherapy into Quitlines

Page 13: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Pharmacotherapy

Medications significantly improve success rates

* Includes pregnant women, smokeless tobacco users, light smokers, and adolescents.

“Providers should encourage all patients attempting to quit to use effective medications for tobacco dependence treatment, except where contraindicated or for specific populations* for which there is insufficient evidence of effectiveness.”

Page 14: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Quit Rates for Cessation Medications

0

5

10

15

20

25

30

Nicotine gum Nicotinepatch

Nicotinelozenge

Nicotinenasal spray

Nicotineinhaler

Bupropion Varenicline

Active drugPlacebo

Graph reprinted with permission, Rx for Change, The Regents of the University of California, University of Southern California, and Western University of Health Sciences.

Per

cen

t q

uit 19.5

14.6

11.5

8.6

16.4

8.8

23.9

11.8

17.1

9.1

20.0

10.2 9.4

22.5

Page 15: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

How does pharmacotherapy help people quit?

• Nicotine is physiologically addictive

• Medications help reduce cravings and withdrawal symptoms

• More medication => higher quit rates

Page 16: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Integrating Medication with Counseling in a Quitline Setting

• Great opportunity to combine counseling and medication to maximize quitting success

• Counselor training and support needs– Knowledge about medications– Protocols and algorithms– Informational tools and resources

• Access to medications– Options and challenges

Page 17: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Factors to consider in recommending pharmacotherapy

• All are safe, effective and well tolerated– Minor side-effects common/adverse events rare– Some use exclusions or contraindications

• Decision support assessment– Number of cigs per day and time to first cigarette– History of prior quit attempts/use of medication– Advantages/disadvantages of each medication– Personal preference

Page 18: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Pharmacotherapy Options• Nicotine replacement products

– Non-prescription: Patches, Gum or Lozenge– Prescription: Oral Inhaler or Nasal Spray

• Non-nicotine products (by prescription only)- Bupropion SR (Zyban) and Varenicline

(Chantix)

Page 19: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Nicotine Gum (2 mg, 4 mg)

Advantages May satisfy oral cravings and delay weight gain Titrate use to manage withdrawal symptoms

Disadvantages Visible use Difficult with dentures or jaw problems/TMJ Must use proper technique to minimize side-effects and

maximize effectiveness

• 2 mg for those smoking less than 25 cpd• 4 mg for those smoking 25 or more cpd• Patients should use ad lib but not exceed 24

pieces per day

Page 20: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Transdermal Nicotine Patch

• 21 mg for those smoking 11+ cigarettes per day• 14 mg for those smoking 5-10 cigarettes per day• 7 mg for those smoking 1-4 cigarettes per day

Advantages Provides consistent nicotine levels Easy to use and conceal Fewer compliance issuesDisadvantages Reactions to adhesive are common Cannot titrate the dose

Page 21: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Nicotine Lozenge (2 mg, 4 mg)

• 2 mg if smoke > 30 minutes after waking• 4 mg if smoke within the first 30 minutes• Should not exceed 20 lozenges per day

Advantages May satisfy oral cravings Easy to use and conceal Titrate to manage withdrawal symptomsDisadvantages Gastrointestinal side effects (nausea, hiccups,

heartburn)

Page 22: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Nicotine Nasal Spray

Advantages Easily titrated with rapid control of withdrawal symptomsDisadvantages Nasal or throat irritation common Dependence can result Must wait 5 minutes before driving or operating heavy

machinery Those with chronic nasal disorders or severe reactive airway

disease should not use

• Rapid onset of action• Doses per hour: 1-2• Maximum doses per day: 40• Maximum duration of treatment: 3 months

Page 23: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Nicotine Inhaler

Advantages Easily titrated to rapidly manage withdrawal symptoms Mimics hand-to-mouth ritual

Disadvantages Mouth and throat irritation common

• Absorbed through oral mucosa (not lung)• 12 week course• Initial dose of 6 to 16 cartridges per day• Frequent continuous puffing for 20 minutes

Page 24: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Bupropion SR (Zyban) • Start 1 week before quit date• 150 mg 1x per day for 3 days• 150 mg 2x per day for duration (7-12 weeks)

Advantages Easy to use Can be taken with NRT May help with depressionDisadvantages Seizure risk is increased Avoid or use with caution in those with history of seizures,

head trauma, eating disorders or heavy alcohol use Use contraindicated with certain medications

Page 25: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Varenicline (Chantix or Champix)

Advantages Unique mechanism of action (partial nicotinic receptor agonist;

lessens withdrawal symptoms and inhibits smoking “reward”) Easy to useDisadvantages Nausea common (up to 40% of users) FDA “black box” warning Use with caution in those with psychiatric diagnosis or history

• Start 1 week before quit date• 0.5mg 1x per day for days 1-3• 0.5mg 2x per day for days 4-7• 1.0 mg 2x per day for 12 weeks

Page 26: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Panelist QuestionsCounseling & Pharmacotherapy

• Is the model your counselors use based on practice, theory or both? Please describe your model.

• How does your quitline address use of medications to quit? – Do you help callers choose medications?– Do you explain how to use the medications?– Are you able provide free or low-cost access to

medications?

• Do you have advice to offer those who are developing or expanding new quitlines?

Page 27: Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.

Thank you!